| DC Field | Value | Language |
|---|
| dc.contributor.author | Ageev, V. P. | - |
| dc.contributor.author | Zaborovskiy, A. V. | - |
| dc.contributor.author | Yunina, D. V. | - |
| dc.contributor.author | Tararina, L. A. | - |
| dc.contributor.author | Devkota, M. K. | - |
| dc.date.accessioned | 2024-08-23T07:34:43Z | - |
| dc.date.available | 2024-08-23T07:34:43Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Development of a transcutaneous form of desloratadine / V.P. Ageev, A.V. Zaborovskiy, D.V. Yunina [et al.] // Research Results in Pharmacology. - 2024. - Vol.10, №2.-P. 57-64. - Doi: 10.18413/rrpharmacology.10.487. - Refer.: p. 63. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/63416 | - |
| dc.description.abstract | The aim of the study: To create a technology for the production of desloratadine-based TTS, suitable for routine use with prolonged drug releasing | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | allergy | ru |
| dc.subject | desloratadine | ru |
| dc.subject | transdermal therapeutic system | ru |
| dc.subject | patch | ru |
| dc.subject | micelles | ru |
| dc.title | Development of a transcutaneous form of desloratadine | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 2
|
